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Abstract
There remains much uncertainty about the relative effectiveness of different non-
pharmaceutical interventions (NPIs) against COVID-19 transmission. Several
studies attempt to infer NPI effectiveness with cross-country, data-driven mod-
elling, by linking from NPI implementation dates to the observed timeline of cases
and deaths in a country. These models make many assumptions. Previous work
sometimes tests the sensitivity to variations in explicit epidemiological model
parameters, but rarely analyses the sensitivity to the assumptions that are made by
the choice the of model structure (structural sensitivity analysis). Such analysis
would ensure that the inferences made are consistent under plausible alternative
assumptions. Without it, NPI effectiveness estimates cannot be used to guide
policy.
We investigate four model structures similar to a recent state-of-the-art Bayesian
hierarchical model. We find that the models differ considerably in the robustness of
their NPI effectiveness estimates to changes in epidemiological parameters and the
data. Considering only the models that have good robustness, we find that results
and policy-relevant conclusions are remarkably consistent across the structurally
different models.
We further investigate the common assumptions that the effect of an NPI is inde-
pendent of the country, the time, and other active NPIs. We mathematically show
how to interpret effectiveness estimates when these assumptions are violated.
1 Disclaimer
This preprint uses the same data as our previous work (Brauner et al. [2]) and references our previous
results at multiple places. However, we have recently updated our data: The new data was collected
with independent double entry and has slightly different NPIs, slightly different NPI definitions, and a
longer window of analysis. We already updated Brauner et al. [2] to use the new data, but the present
preprint is still in the process of being updated. In the meantime, the results differ slightly between
the two preprints.
∗Equal contribution. Correspondence to Mrinank Sharma, <mrinank@robots.ox.ac.uk>.
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However, this does not affect the claims made in this preprint. The exact version of the data used is
linked in Section 4.
2 Introduction
Nonpharmaceutical interventions (NPIs), such as business closures, gathering bans, and stay-at-home
orders, are a central part of the fight against COVID-19. Yet it is largely unknown how effective
different NPIs are at reducing transmission [2, 7]. Better understanding is urgently needed to guide
policy and help countries efficiently suppress the disease without putting unnecessary burden on the
population. We can infer NPI effectiveness by assuming that the implementation of an NPI affects
the course of a country’s epidemic in a particular way, and then observing that course. Standard
tools such as PyMC3 [23] and Stan [3] allow this inference to be performed in an automated way.
A data-driven analysis like this can only disentangle the effects of individual NPIs if the data is
sufficiently diverse. However, this is indeed the case, as different countries implemented different
NPIs, in different orders and at different stages of their epidemics. We thus believe that such analysis
can be fruitful given a large enough dataset.
However, constructing an appropriate data-driven NPI effectiveness model is challenging and must
be accompanied by extensive validation. Firstly, an analysis of holdout predictive performance is
required [11, 12]. Of course, prediction is not the model’s primary purpose and strong prediction
does not imply correct NPI effect estimates. However, holdout predictive performance can be used to
rule out models: there is little reason to trust an NPI model which fails to predict on heldout data. We
can reasonably assume that a significant fraction of the variance in national cases and deaths can be
explained by the NPIs a country implements. A NPI model that includes the major NPIs should thus
give broadly reasonable predictions for cases and deaths in held-out countries and periods. In our
previous work, we analyse holdout performance by holding out the last 20 days in all countries in
parallel, and holding out each country one at a time [2]. However, holdout performance validation
is often limited or absent in other previous work. The majority of studies do not report holdout
performance [1, 4, 17, 18, 10, 14].2 Flaxman et al. [7] hold out the last three days in all countries in
parallel.
Secondly, results need to be robust to variations in all components of the analysis for which there
is no strong justification for choosing one particular setting [25, 21]. This applies to the following
components:
• Epidemiological parameters.3 Key epidemiological parameters remain uncertain and con-
flicting results are common (Supplement Table 2).
• Model structure. How NPIs interact is unknown, and the process of transmission can only
be modeled with approximations [22, 9]. Indeed, models commonly make a large number
of approximating assumptions (Section 3).
• Data. Given the difficulty of collecting data during an ongoing pandemic, any analysis will
be limited to a subset of countries and NPIs, and there is no strong justification for in-or
excluding one particular country or NPI.
• Hyperparameters (sometimes).4 If a model has good holdout performance over a range of
hyperparameter values, there is no strong justification for picking one particular value.
While sensitivity analyses are more common than holdout validation in previous work, often only a
small subset of epidemiological parameters are examined and sensitivity to model structure (structural
sensitivity) is not evaluated. Flaxman et al. [7] check sensitivity to the serial interval and leaving
out individual countries, fit the reproduction number (R, the expected number of infections directly
generated by one infected individual) with a non-parametric model, and compare to an alternative
model of R0. Banholzer et al. [1] check the sensitivity of their results to the delay from infection
to reporting, the threshold initial case count, influential single data points, the form of the influence
function, and restricting NPI effectiveness to be positive. Jarvis et al. [14] varied the post-lockdown
2We focus on multi-NPI studies here, but holdout validation is also absent from all single-NPI studies we are
aware of.
3By ‘epidemiological parameters’ we mean those that describe properties of the disease or NPIs investigated.
4By hyperparameters we mean unlearned parameters which do not correspond to properties of the disease or
NPIs.
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contact reduction among young people. Many NPI studies do not mention sensitivity or validation at
all [4, 20, 5, 16, 19, 18, 10].
Our contributions:
• i) We present commonly used assumptions in NPI effectiveness studies.
• ii) We reproduce two prior models [2, 7] and construct three plausible alternative models.
We empirically validate them, finding that one of the prior models has poor robustness.
• iii) We analyse the robustness of our previously reported NPI effectiveness results [2]
across four structurally different models with different modelling assumptions. We find that
results and policy-relevant conclusions are remarkably robust to changes in epidemiological
parameters, data, and model structure.
• iv) All previous work assumes that an NPI’s effect does not depend on other active NPIs, on
the country, or the date. We mathematically show how to interpret effectiveness estimates
when these assumptions are violated. Furthermore, we provide weak empirical evidence
that, in our data, the assumption that NPI effectiveness is independent of other active NPIs
is not a significant limitation.
3 Common assumptions in NPI modelling
We now reproduce the model of our previous work [2], using this as our baseline, and explicitly collect
the assumptions used in the model. We discuss key assumptions in detail but defer a full discussion
of the implications of all assumptions to the Supplement (Section A.4). We further list other works
which make use of these assumptions and propose a number of plausible models with different
structural assumptions. Please refer to the Supplement for full model descriptions (Section A.7).
Notation. The basic reproduction number for country c (i.e. the reproduction number in the absence
of any NPIs) is R0,c. The time-varying (instantaneous [9]) reproduction number at time t in country
c is Rt,c, which we use as the measure of transmission. φi,t,c are binary NPI activation features with
φi,t,c = 1 indicating that NPI i is active in country c at time t. Ct,c and Dt,c represent the number of
daily reported cases and deaths respectively. The set of NPIs is denoted as I . Nt,c represents (scaled)
numbers of new daily infections. αi ∈ R parameterizes the effectiveness of NPI i.
3.1 Baseline (Model 1)
Assumption 1. Epidemiological parameters are constant across countries and time [7, 1, 4, 17, 20, 2].
Remark. Supplement Table 2 outlines the epidemiological parameters required by all our models. In
addition, our models place iid prior distributions over: NPI effectiveness, αi; initial outbreak sizes,
N0,c; country-specific base reproduction rates R0,c (through a hyper-prior). Other than the prior over
N0,c, which is uninformative, we consider these priors to be epidemiological parameters and include
them in our sensitivity analysis.
Assumption 2. The effectiveness of NPI i is independent of other active NPIs [7, 1, 6, 2].
Remark. The manner and extent to which different NPIs interact is unclear, and depends on the
specific NPIs. For example, school closure and symptomatic testing are unlikely to interact, whilst
social distancing measures may reduce the effectiveness of mask wearing.
Assumption 3. The effectiveness of NPI i is independent of the country [7, 1, 4, 20, 2].
Assumption 4. The effectiveness of NPI i is independent of time [7, 1, 4, 20, 2].
Assumption 5. The effectiveness of NPI i is independent of its implementation date [7, 1, 4, 20, 17,
2].
Assumption 6. Each NPI has a multiplicative effect on Rt,c [7, 1, 4, 2].
Assumption 7. Rt,c depends only on R0,c and active NPIs (which are denoted by {φi,c,t}i∈I)
[7, 1, 4, 2].
Therefore, each NPI has its full effect on Rt,c immediately. In Appendix A.4, we discuss to what
extent this assumption allows causal inference.
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Assumptions 2 to 7 lead to:
Rt,c = R0,c
∏
i∈I
exp(−αiφi,t,c), (1)
where αi > 0 is interpreted as NPI i being effective.
Let the discrete time growth rate be gt,c, such that Nt,c = gt,cNt−1,c.
Assumption 8. It is valid to convert Rt,c to gt,c under exponential growth [24]:
gt,c = exp
(
M−1SI (R
−1
t,c )
)
, (2)
where M−1SI is the inverse of the moment-generating function of the serial interval distribution [2],
[7] (in sensitivity analysis).
Assumption 9. The Infection Fatality Rate (IFRc), the proportion of infected cases that subsequently
die, and the Ascertainment Rate (ARc), the proportion of infected cases that are subsequently reported
positive (both in country c) change slowly over time [2].
Assumption 10. The effective growth rate, in expectation, is the same for both cases and deaths [2].
We can now write:
N
(C)
t,c = N
(C)
0,c
t∏
t′=1
[
gt′,c · exp
(
ε
(C)
t′,c
)]
, N
(D)
t,c = N
(D)
0,c
t∏
t′=1
[
gt′,c · exp
(
ε
(D)
t′,c
)]
(3)
with noise terms ε(C)t′,c , ε
(D)
t′,c ∼ N (0, σ2g). N (C)t,c and N (D)t,c represent the daily new infections on day
t, in country c, which will become confirmed cases and fatalities.
Remark. The noise terms allow for small, gradual changes in the AR and IFR [2]. Crucially, noise
ε
(C)
t′,c affects N
(C)
t,c for all t ≥ t′. Differences in IFRc and ARc are accounted for by latents N (C)0,c
and N (D)0,c , which represent initial outbreak sizes. Concretely, if the true number of infections in
country c is the same as country c′ ∀t but c tests a greater proportion of the population, we can infer
N0,c > N0,c′ .
Remark. These noise terms also partially relax Assumption 7, as they can account for the effects
of unobserved NPIs, providing that they are uncorrelated with the observed NPIs [6]. However, if
unobserved NPI i is correlated with observed NPI j, the effect of NPI i may be attributed to NPI j.
Discrete convolutions produce the expected number of new reported cases C¯t,c and deaths D¯t,c on a
given day:
C¯t,c =
31∑
τ=1
N
(C)
t−τ,cpiC [τ ], D¯t,c =
63∑
τ=1
N
(D)
t−τ,cpiD[τ ], (4)
where piC [τ ] represents the probability of the delay between infection and confirmation being τ
days, produced by summing the incubation period with the onset-to-confirmation distributions and
discretising. Analogous, piD[τ ] is produced by summing the incubation period with the onset-to-death
distribution.
Assumption 11. The output distribution of confirmed cases Ct,c and deaths Dt,c follows a Negative
Binomial noise distribution [7, 2, 1].
Ct,c ∼ NB(µ = C¯t,c, A = Ψ), Dt,c ∼ NB(µ = D¯t,c, A = Ψ) (5)
A is the dispersion parameter of the distribution, with larger values of A corresponding to less noise;
Ψ is its inferred estimate. This distribution is suitable as it has support over N0, and has independent
mean and variance parameters.
The models we describe next branch from this baseline model.
3.2 Additive Effect Model (Model 2)
To investigate Assumption 6, we propose a model where interventions have additive effects on Rt,c.
Assumption 12. NPI i has an additive effect on Rt,c by affecting a non-overlapping, constant
proportion of initial transmission. The introduction of NPI i eliminates all transmission related to i.
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This leads to:
Rt,c = R0,c
(
αˆ+
∑
i∈I
αi (1− φi,t,c)
)
, with αˆ+
∑
i∈I
αi = 1, (6)
αi > 0 ∀i and αˆ > 0. αi is the proportion of transmission eliminated by introducing NPI i.
3.3 Noisy-R Model (Model 3)
Instead of adding noise to Nt,c as in Eq. 3, we could add noise directly to Rt,c as:
R
(C)
t,c = R¯t,c exp ε
(C)
t,c , R
(D)
t,c = R¯t,c exp ε
(D)
t,c , (7)
where ε(C)t,c , ε
(D)
t,c ∼ N (0, σ2R). This noise has the same implications as in Eq. (3). Overall, this
model makes the same assumptions as the baseline model, so it would be concerning if results were
not consistent across these models.
3.4 Discrete Renewal Model (Model 4)
Model 4 is based on Flaxman et al. [7].
Assumption 13. IFRc and ARc are constant over time. [7, 17, 1].
Remark. While the true IFR may be approximately constant, reporting is imperfect, and the
proportion of COVID-19 related deaths captured by official statistics changes over time. Indeed,
Fig. 3 (Supplement) shows the ratio between reported deaths and excess deaths, i.e., the deaths in
excess of the historical average. This ratio changes notably in every country studied. As the modelled
IFRc is the ratio of confirmed COVID deaths to infections, we thus do not expect it to be constant
over time. Furthermore, the assumption that ARc is constant is especially problematic, since we
expect testing capacity to vary over time. Nevertheless, these assumptions are common.
We investigate Assumption 8 by using a discrete renewal process ([8, 20]) in place of Eq. (3). Let
piSI [τ ] represent the discretised serial interval distribution. We then write:
N
(C)
t,c = Rt,c
t∑
τ=1
N
(C)
t−τ,c · piSI [τ ], N (D)t,c = Rt,c
t∑
τ=1
N
(D)
t−τ,c · piSI [τ ], (8)
Modelling only deaths yields the model of Flaxman et al. [7] with N (D)c,t taking the place of
IFRc · N truec,t in [7]. While our baseline partially relaxes Assumption 7, this model relies on R0,c,
active NPIs, and output noise to explain unobserved effects.
3.5 Different Effects Model (Model 5)
Our previous models share Assumptions 2 and 3 that we now relax. Denote the effectiveness of NPI i
in country c as αi,c.
Assumption 14. The country-specific NPI effectiveness parameters, {αi,c}c, are drawn iid according
to N (αi, σ2α). σα is a noise scale hyper-parameter.
Remark. The effect of NPI i in country c may depend on the other NPIs which are active (since
Assumption 2 may not hold) as well as the exact implementation of i in that country. Thus Assump-
tion 14 relaxes both Assumptions 2 and 3.
4 Experiments
Data. We use NPI data from [2], which comprises fact-checked data on the implementation of 9
NPIs in 41 countries between January and April 2020, and data on reported COVID-19 cases and
deaths from the Johns Hopkins CSSE tracker [15]. See the Supplement for pre-processing details.
Implementation. We implement our models in PyMC3 [23] with NUTS [13] for inference. We
typically use 4 chains, 2000 samples per chain (occasionally 8 chains, 1000 samples each). We ensure
that the Gelman-Rubin Rˆ is less than 1.05 and that there are no divergent transitions. Our sensitivity
analyses and model implementations are available here.
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Hyperparameters. Noise scales (σg or σR, σα) are chosen to give good holdout performance.
Model evaluation. We evaluate holdout performance by 4-fold cross-validation, holding out all but
the first 14 days of cases and deaths (to allow estimation of R0,c and N0,c). We only evaluate on
countries with >100 deaths, as we want to evaluate models by their accuracy and calibration over
long time periods, and countries with fewer deaths usually have fewer relevant days. We measure
holdout performance as the held out log-likelihood, averaged over days and countries.
As in our previous work [2], we perform extensive sensitivity experiments across several categories.
Epidemiological parameter sensitivity, including: varying the infection-to-death and infection-to-
confirmation delay distribution means, the serial interval distribution mean, the prior distributions on
αi (NPI effectiveness), and the hyperprior distribution on R0. Data sensitivity, including: leaving out
one country at a time; leaving out one NPI at a time; varying the cumulative-case-threshold below
which days are masked; switching the school closure NPI in Sweden on/off 5.
We summarise the sensitivity of a model using two worst-case categorised sensitivity scores: Lmed,
which describes the sensitivity in median effectiveness, and Lσ , which describes the sensitivity of the
model’s posterior standard deviation, or confidence.
Lmed =
∑
c∈categories
max
i∈I,test∈c
{∣∣∣median[α˜(test)i ]−median[α˜(default)i ]∣∣∣} (9)
test ∈ c represents a specific test of category c. For example, c might represent the category of
varying the distribution of a specific epidemiological parameter, and test would correspond to one
particular value for the parameter(s) of that distribution. α˜i is the effectiveness of NPI i converted
into a percentage reduction of R, α˜(default)i is the effectiveness under default data and epidemiological
parameters. The definition of Lσ is analogous, but the median is replaced by the standard deviation
of the effectiveness. Larger values of Lmed and Lσ correspond to more sensitive models. We take the
maximum over NPIs and tests because we find that tests often significantly affect a small subset of
the NPIs.
5 Results & Discussion
Baseline model (Model 1). We first reproduce the model, results, and sensitivity analyses of our
previous work [2]. The key conclusions of this work are summarised in Supplementary Table 3.
For brevity, we do not further discuss the results and their implications here, but refer the reader to
[2]. The results are remarkably robust to changes in the data and hyperparameters, as well as across
plausible ranges of epidemiological parameters (Supplement Fig. 4). In particular, the results are
robust to leaving out one NPI at a time, indicating that the model can successfully ignore unobserved
confounders (i.e., is robust to violations of Assumption 7). We tend to see systematic trends when
varying epidemiological parameters (delays and serial interval), suggesting that, while they may
affect effectiveness estimates, they do not affect conclusions about relative effectiveness.
Model comparison. We implement 4 alternative models with different model structure (Models 2
- 5), tuning their hyperparameters and comparing them based on holdout predictive performance
and robustness. All of the models have similar holdout predictive performance and give broadly
reasonable predictions for cases and deaths in held-out countries (Supplement, Section A.2). However,
while Models 1,2,3, and 5 have broadly comparable robustness, the discrete renewal model fares
significantly worse (Fig. 1). This suggests that holdout performance is insufficient for model selection,
and sensitivity analysis is essential. In general, the median effectiveness of each model varies more
than the model’s confidence, for most categories. Posterior predictive distributions are shown in the
Supplement (Figure 5).
Structural sensitivity analysis. We only require results to be robust across different model structures
if there is no strong justification for choosing one structure over the other. The poor robustness of the
renewal model ([7]) justifies not choosing it6 , so we do not include it in our structural sensitivity
analysis. Fig. 2 displays the inferred NPI effectiveness for models 1,2,3, and 5, using the same "best
5Sweden closed high schools and universities, but not elementary schools. Brauner et al. [2] counted this as
"schools closed", but Banholzer et al. [1] counted this as "schools open".
6In a fully Bayesian approach, where we explicitly model our uncertainty over epidemiological parameter
distributions and data, a model with high sensitivity would have wide posterior credible intervals. It thus does
little to constrain our beliefs about the true NPI effects, compared to models with lower sensitivity.
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Figure 1: Contributions to sensitivity score from different categories: Left: categorised sensi-
tivity to data perturbations, by model. Right: categorised sensitivity to variations in epidemio-
logical parameters.
guess" (default) setting for epidemiological parameters for all models. The inferred NPI effectiveness
estimates are remarkably robust across all models based on multiplicative effects. The results of
the Additive Effect Model cannot be directly compared, as αi have different meaning between the
additive and the multiplicative models. However, the trends in the relative effectiveness of different
NPIs are consistent across additive and multiplicative models.
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Figure 2: Left: NPI effectiveness under different structural assumptions, using the same "best
guess" (default) setting for epidemiological parameters for all models. The figure shows the
median, inter-quartile range and 95% confidence intervals of the posterior distributions of
αi. Note that the Additive Effect Model cannot directly be compared to the other (multiplica-
tive) models. The Additive Effect Model parameterises NPI effects as a reduction in R0, while
the multiplicative models parameterise effects as a reduction in Rt (Section 3). Right: Dis-
tribution of NPI effectiveness ranks. We performed more than 150 different experiments (4
structurally different models, each evaluated under 7 categories of data and parameter varia-
tion, with several settings per category). The colour of the square indicates in what percentage
of experiments the NPI was the xth most effective (judged by median posterior effectiveness).
It is particularly interesting to evaluate the robustness of high-level conclusions that might guide
policymakers. One such high-level conclusion is the ranking of NPIs. Ranked by median effectiveness,
we find remarkable robustness in NPI rankings (Fig. 2R): for example, the most and least effective
NPI are the same across more than 150 experiment settings. Furthermore, we list policy-relevant
conclusions from Brauner et al. [2], operationalise them, and count the fraction of tested parameter
and model structure settings each conclusion holds in (Table 1). Again, all high-level conclusions are
highly robust.
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Table 1: Robustness of the main conclusions of Brauner et al. [2]. First column. Brief re-
statement of the conclusion. See Table 3 for details. Second column. Operationalisation to
make the qualitative conclusions testable in the sensitivity analyses. Third column. Percentage
of experiments in which the conclusion holds. We performed more than 150 different experi-
ments (4 structurally different models, 7 categories of data and parameter variation, several
settings per category). ∗The Additive Effects model constrains αi to positive values, so we change the
operationalisation of the conclusion about testing for the Additive Effects model, to "The probability of
the ’Symptomatic testing’ NPI reducing R by more than 1% is≥ 90%." This conclusion is generally not
supported by the additive effects model, which finds this to hold for only approximately 10% of sensitivity
tests.
Conclusion Operationalisation Holds in
[%]
Closing schools has a surpris-
ingly large effect
The ’School closure’ NPI has the highest median
effectiveness of all NPIs.
100%
Closing most nonessential
businesses has limited bene-
fit over closing only high-risk
businesses
The percentage reduction in R from closing high-
risk businesses is at least 150% of the additional
percentage reduction in R from closing most
nonessential businesses (over closing just high-risk
businesses).
100%
Symptomatic testing has a
demonstrable effect
The posterior probability of the ’Symptomatic test-
ing’ NPI being effective is ≥ 90%.*
74.8%
A stay-at-home order (with ex-
emptions) has comparatively
small effect
The ’Stay-at-home order’ NPI was in the bottom 4
NPIs in terms of median effectiveness.
100%
6 Effectiveness in Context
Except Model 5, our models rely on Assumptions 2, 3, and 4 i.e., they assume an NPI’s effect
is independent of the other active NPIs, the implementing country, and time. In practice, these
assumptions are likely violated. For instance, mask wearing probably has a greater effect on R when
no social distancing measures are in place. Furthermore, the implementation of NPIs differs across
countries. For example, some countries required residents to fill out an official permit form if they
wanted to leave their home during a stay-at-home order, whilst others did not. In addition, NPI
adherence, and thus effectiveness, is unlikely to be constant over time.
How should effectiveness estimates be interpreted when these assumptions are violated? To gain
insight, we assume that ground truth values of gt,c and R0,c have been provided to us. Consider
Model 1, where the noise is applied to gt,c and Model 3, where the noise is applied to R.
Model 1. gt,c = g(Rt,c) exp(εt,c), with Rt,c = R0,c
∏
i∈I exp(−αiφi,t,c).
Model 3. gt,c = g(Rt,c), with Rt,c = R0,c exp(εt,c)
∏
i∈I exp(−αiφi,t,c).
As usual, εt,c ∼ N (0, σ2). Recall that Assumption 8 lets us write log g(R) = β
(
R1/ν − 1),
where ν is the shape and β is the inverse scale of the SI distribution, which is assumed to
be a Gamma(ν, β) distribution [2, 7]. We have used the well known analytical expression
for MSI(·). Let Φi = {(t, c)|φi,t,c = 1} be the days and countries with NPI i active. Let
R˜(−i),t,c = R0,c
∏
j∈I\{i} exp(αjφj,t,c) i.e., R˜(−i),t,c is the predicted R ignoring the effect of
NPI i. We present the following results in terms of exp(−αi), the factor by which NPI i reduces R.
Theorem 1. The Maximum Likelihood (ML) solution of αi, given {αj}j 6=i, under Model 3 satisfies:
exp(−αi) =
(∏
(t,c)∈Φi Rt,c
)1/|Φi|
(∏
(t,c)∈Φi R˜(−i),t,c
)1/|Φi| = M0( {Rt,c}Φi )M0( {R˜(−i),t,c}Φi ) , (10)
where M0(S) denotes the geometric mean of set S . The ML solution for exp(−αi) is the ratio of two
geometric means over all country-days when NPI i is active: the numerator is the mean ground-truth
Rt,c and the denominator is the mean of the predicted value of Rt,c if NPI i was deactivated.
8
Theorem 2. The ML solution of αi, given {αj}j 6=i, under Model 1 satisfies:
exp(−αi) =
 ∑
(t,c)∈Φi
R˜
1/ν
(−i),t,cR¯
1/ν
t,c
ν/ ∑
(t,c)∈Φi
R˜
1/ν
(−i),t,cR˜
1/ν
(−i),t,c
ν = MWi1/ν({R¯t,c}Φi)
MWi1/ν({R˜(−i),t,c}Φi)
(11)
where MWi1/ν(S) is the generalized weighted mean of set S, with exponent 1/ν and weights
Wi = {wc,t = (R˜(−i),t,c) 1ν }. R¯t,c is the "observed" R that exactly corresponds to the observed g.
Proofs: See Supplement.
Notably, the minor variation in model structure gives a significant difference in ML solutions; the
ML solution of Model 3 is a ratio of geometric means whilst that of Model 1 is a ratio of generalized
weighted means that weights observations more when the predicted R, excluding NPI i, is larger.
However, in both models, when assumptions 2, 3 and 4 do not hold, αi can be interpreted as an
average additional effectiveness, since it is produced by averaging over the data distribution.
Empirical investigation. Recall that the Different Effects model relaxes Assumptions 2 and 3.
Allowing NPI effects to vary across countries enables modelling both country-level differences as
well as interactions with other NPIs: if NPI j is less effective when NPI i is active, the noise will
reduce the estimated effectiveness of NPI j in countries where i and j are both active. Supplementary
Figures 6 and 7 show country-specific effectiveness estimates for NPIs, as well as conditional NPI
activation plots for the countries in which each NPI was most and least effective. If an NPI’s effect
was heavily influenced by the presence of other NPIs, we would expect the activation patterns
of the other NPIs to differ between the countries in which the NPI was most and least effective.
Surprisingly, we do not find this difference in NPI activation pattern (Supplement, Figs. 6, 7). We
know that Assumption 2 does not hold in practice, but we conclude that Assumption 3 is a more
significant limitation in this data, since NPI effectiveness estimates seem to be more influenced by
other country-specific factors than the presence or absence of other NPIs.
7 Conclusions
We show that our previously reported NPI effectiveness results [2] are remarkably robust across
several alternative model structures. For a discussion of the NPI effectiveness results and their
implications, we refer the reader to [2]. We have publicly released our sensitivity analysis suite and
model implementations, and we urge those working on estimating NPI effectiveness to not only
systematically validate their models, but also to report this.
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A.1 Additional Figures and Tables
Table 2: Key epidemiological parameters, with reported estimates for COVID-19. Epidemiological
parameters remain uncertain, and conflicting results are common.
Parameter Definition Reported values
Serial-Interval (SI) distribu-
tion
The distribution of the period (in days)
taken for one infected individual to gen-
erate R new infections. Gamma dis-
tributed.
µ=5.1, σ=2.7 [1]
µ=7.5, σ=3.4 [2]
µ=6.7, σ=4.9 [3]
Incubation period distribu-
tion
The distribution of the period (in days)
between infection and onset of symp-
toms. Gamma distributed.
µ=5.2, σ=2.5 [1]
µ=6.0, σ=3.1 [4]
µ=5.1, σ=4.4 [5]
Onset-to-confirmation dis-
tribution
The distribution of the period (in days)
between symptom onset and case confir-
mation. Gamma in [1]; Negative Bino-
mial in [3]; lognormal in [1].
µ=2.6, σ=3.22 [1]
µ=3.68, σ=16.6 [1]
µ=5.25, σ=4.8 [3]
Onset-to-death distribution The distribution of the period (in days)
between symptom onset and death.
Gamma distributed.
µ=18.8, σ=8.5 [6]
µ=15, σ=6.9 [4]
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Days since 10th reported COVID death
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Figure 3: Ratio of reported COVID-19 deaths to overall excess deaths (deaths in excess of the
historical average), over time & by country. At the start of the epidemic in each country, we might
expect the number of excess deaths to closely track the true number of COVID-19 deaths. The
ratio between reported COVID-19 deaths and excess changes notably over time, suggesting that
Assumption 13 is violated. Data from [7].
Table 3: Conclusions of Brauner et al. [8]
Conclusion
Closing schools seems to play a surprisingly large role in reducing COVID-19 transmission.
Closing high-risk businesses, such as bars, restaurants, and gyms, appears only slightly less effective
than closing most nonessential businesses (while imposing a substantially smaller burden on the
population).
Testing of symptomatic patients has a demonstrable effect on reducing COVID-19 transmission.
A stay-at-home order (with exemptions) has a comparatively small effect on reducing COVID-19
transmission.
(Explanation from Brauner et al. [8]: "We estimate a comparatively small effect for stay-at-home orders. The
‘stay-at-home order (with exemptions)’ NPI should be interpreted literally: a mandatory order to generally
stay at home, except for exemptions. When countries introduced stay-at-home orders, they nearly always also
banned gatherings and closed nonessential businesses and schools if they had not done so already. Accounting
for the effect of these NPIs, it is not surprising that the additional effect of ordering citizens to stay at home is
small-to-moderate.")
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-100% -50% 0% 50% 100%
Mask Wearing
Symptomatic Testing
Gatherings <1000
Gatherings <100
Gatherings <10
Some Businesses Suspended
Most Businesses Suspended
School Closure
Stay Home Order
Default
-100% -50% 0% 50% 100%
Delays
Default
Cases: 2 days
Cases: 1 days
Cases: +1 days
Cases: +2 days
Deaths: 2 days
Deaths: 1 days
Deaths: +1 days
Deaths: +2 days
-100% -50% 0% 50% 100%
Epidemiological Priors
Default
( [R] = 3.25,
i (0, 0.22))
[R] = 1.5
[R] = 5.5
i
+ (0, 0.22)
i (0, 102)
-100% -50% 0% 50% 100%
Mask Wearing
Symptomatic Testing
Gatherings <1000
Gatherings <100
Gatherings <10
Some Businesses Suspended
Most Businesses Suspended
School Closure
Stay Home Order
Minimum Confirmed Cases
Default (100)
10
30
300
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Reduction in R
Mobility
Default
Retail & Recreation
Workplace & Retail &
Recreation
-100% -50% 0% 50% 100%
Reduction in R
NPI Leaveouts
Default
Mask Wearing
Symptomatic Testing
Gatherings <1000
Gatherings <100
Gatherings <10
Some Businesses
Suspended
Most Businesses
Suspended
School Closure
Stay at Home Order
-100% -50% 0% 50% 100%
Reduction in R
Mask Wearing
Symptomatic Testing
Gatherings <1000
Gatherings <100
Gatherings <10
Some Businesses Suspended
Most Businesses Suspended
School Closure
Stay Home Order
Region Holdouts
Default
CZ
DE
MX
NL
PL
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Reduction in R
SE Schools
Default
SE Schools Open
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Serial Interval
Default ( = 6.67)
= 4
= 5
= 6
= 7
= 8
Figure 4: Categorised sensitivity analysis results for the baseline model. Median, inter-quartile
range and 95% confidence intervals shown. Black values correspond to default parameter settings.
Mobility shows the results if Google mobility data is added as an “NPI” as a proxy for unobserved
behaviour changes. We expect some NPIs to be mediated through changes in mobility (e.g. business
closures, stay-at-home orders) and thus expect to see changes in these NPIs, but not others. We
include mobility in retail and recreation areas, and additionally in workplace areas.
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Figure 6: Left: Country-specific effectiveness for different NPIs, sorted by posterior median effec-
tiveness (Different Effects Model). Right: Denote the NPI in question as NPI j. Similar NPIs are
co-activated in the countries where NPI j is estimated to be the most effective (above white line) and
the least effective (below white line). This suggests that country specific factors are more significant
than the context independence assumption.
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Figure 7: Left: Country-specific effectiveness for remaining NPIs, sorted by posterior median
effectiveness (Different Effects Model). Right: Denote the NPI in question as NPI j. Similar NPIs are
co-activated in the countries where NPI j is estimated to be the most effective (above white line) and
the least effective (below white line). This suggests that country specific factors are more significant
than the context independence assumption.
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A.2 Holdouts
We evaluate holdout performance by 4-fold cross-validation, holding out all but the first 14 days of
cases and deaths (to allow estimation of R0,c and N0,c). Figure 8 shows holdout predictions on the
first fold. Prediction performance is very similar across the models.
Note that the hyperparameters (σg or σR, σα) were tuned on one of the four folds used for model
evaluation. Figure 8 thus presents holdouts on the validation set and slightly overstates the predictive
capabilities of the models. However, we think this bias is small because, empirically, the holdout
likelihood varies only slightly across the 5 values of the hyperparameter evaluated.
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Figure 8: Holdout country plots for the first fold of cross-validation.
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A.3 Full sensitivity results for all models
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Figure 9: Categorised sensitivity analysis results for the additive model. Median, inter-quartile
range and 95% confidence intervals shown. Black values correspond to default parameter settings.
Mobility shows the results if Google mobility data is added as an “NPI” as a proxy for unobserved
behaviour changes. We expect some NPIs to be mediated through changes in mobility (e.g. business
closures, stay-at-home orders) and thus expect to see changes in these NPIs, but not others. We
include mobility in retail and recreation areas, and additionally in workplace areas.
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Figure 10: Categorised sensitivity analysis results for the Noisy-R model. Median, inter-quartile
range and 95% confidence intervals shown. Black values correspond to default parameter settings.
Mobility shows the results if Google mobility data is added as an “NPI” as a proxy for unobserved
behaviour changes. We expect some NPIs to be mediated through changes in mobility (e.g. business
closures, stay-at-home orders) and thus expect to see changes in these NPIs, but not others. We
include mobility in retail and recreation areas, and additionally in workplace areas.
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Figure 11: Categorised sensitivity analysis results for the different effects model. Median, inter-
quartile range and 95% confidence intervals shown. Black values correspond to default parameter
settings.Mobility shows the results if Google mobility data is added as an “NPI” as a proxy for
unobserved behaviour changes. We expect some NPIs to be mediated through changes in mobility
(e.g. business closures, stay-at-home orders) and thus expect to see changes in these NPIs, but not
others. We include mobility in retail and recreation areas, and additionally in workplace areas.
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Figure 12: Categorised sensitivity analysis results for the discrete renewal model of [9]. Median,
inter-quartile range and 95% confidence intervals are shown. Black values correspond to default
parameter settings.Mobility shows the results if Google mobility data is added as an “NPI” as a proxy
for unobserved behaviour changes. We expect some NPIs to be mediated through changes in mobility
(e.g. business closures, stay-at-home orders) and thus expect to see changes in these NPIs, but not
others. We include mobility in retail and recreation areas, and additionally in workplace areas.
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A.4 Discussion of assumptions
We proceed by discussing the assumptions (and their implications) listed in section 3, for which
further discussion is necessary.
Assumption 6 states that each NPI’s effect on Rt,c is multiplicative. This implies that each NPI
has a smaller effect when Rt,c is already lowered by other NPIs. Such an assumption may be
appropriate because e.g. an active stay-home order decreases the effect of wearing masks in public
spaces. However, it may be inappropriate for other NPIs. For example, suppose a given proportion of
transmission happens in schools and a given proportion in businesses. In such a situation, closing
schools is expected to decrease Rt,c by the same amount, whether or not businesses are closed. This
leads to an alternative model based on Assumption 12, where the effect of each NPI is additive
(reprinted from equation (6)):
Rt,c = R0,c
(
αˆ+
∑
i∈I
αi (1− φi,t,c)
)
, with αˆ+
∑
i∈I
αi = 1, (12)
where the parameter αˆ represents the proportion of transmission that still happens when all NPIs are
active.
Assumption 7 states that Rt,c depends only on each country’s initial reproduction number R0,c and
the active NPIs. In other words, no unobserved factors are changing Rt,c, such as spontaneous social
distancing. This is a crucial assumption since the effect of unobserved factors may otherwise be
attributed to the active NPIs. This can happen under specific conditions. Firstly, the unobserved effect
cannot be present throughout the entire study period since otherwise R0,c accounts for it. Secondly,
its timing must be correlated with that of an NPI since otherwise it will be modeled as noise. Under
these conditions, an unobserved effect constitutes an unobserved confounder [10, 11] or another
biasing factor such as a mediator or suppressor. For statistical purposes, there is an equivalence
between these types of unobserved effects [12] so we restrict the discussion to confounding.
Without unobserved confounders, our models can infer the causal effects of the studied NPIs. This is
a property of regression models, such as ours, when their specification is correct [13]. To understand
this point intuitively, it is worth examining the simplified models used in section 6.
The effect of unobserved confounders is usually examined by introducing artificial confounders and
observing how much this affects results [10, 11]. We tested each model’s sensitivity to unobserved
confounders by making each NPI unobserved, in turn (Figures 4 and 9– 12). Results were stable
except when hiding the most effective NPI, school closures. Results may therefore be affected by
confounding if unobserved confounders caused a large reduction in R0,c (ca. 50%, which is the
inferred effect for school closures).
Brauner et al. [8] performed a further sensitivity check where they added mobility data as an ‘NPI’
that serves as a proxy for unobserved confounders. We did not include this for the calculation of our
sensitivity metrics, the worst-case categorised sensitivity scores Lmed and Lσ , because mobility is not
just a confounder but a mediator for the effect of some NPIs, so the inferred effects of these NPIs
should change. (We do, however, show the tests with mobility data in Figures 4 and 9– 12). Brauner
et al. [8] found that indeed the inferred effects are significantly decreased only for those NPIs whose
effect is mediated through retail and recreation mobility (business closures and stay-home orders,
as well as a slight change for gathering bans). However, for the other NPIs, adding mobility data
appears to be a sensible check for sensitivity to unobserved confounding.
Assumption 9 states that the country-specific infection fatality rate (IFRc) and ascertainment rate
(ARc) only change in small steps. Assumption 13, implicitly made in [9], states that they do not
change at all. Small changes over time are modeled by the noise terms ε(C)t′,c , ε
(D)
t′,c ∼ N (0, σ2g).
Noise at time t changes all future infections, mimicking the effect of a change in the IFR or AR. In
the sensitivity analyses, models that lack these noise terms perform significantly worse than others
(Figure 1).
Note that, in principle, it is possible to distinguish changes in the IFR and AR from the NPIs’
effects: decreasing the ascertainment rate decreases future cases Ct,c by a constant factor whereas
the introduction of an NPI decreases them by a factor that grows exponentially over time.
24
A.5 Proofs of Theorems 1 and 2
Proof of Theorem 1. For this model, assume that ground truth values of Rt,c have been given to us.
By definition, we can write:
logRt,c = logR0,c −
∑
i∈I
αiφi,t,c + εt,c (13)
where εt,c ∼ N (µ = 0, σ2 = σ2R); σR and R0,c are fixed parameters, φi,t,c ∈ {0, 1} and Rt,c are
given. We want to find the maximum likelihood solution for {αi}i∈I .
The log-likelihood L is given as
L =
∑
t,c
logN (εt,c|0, σ2R) = −
1
2σ2R
∑
t,c
ε2t,c + constant, (14)
where the constant does not depend on the values of {αi}i∈I . Assume that values {αj}j∈I,j 6=i are
fixed and we are finding the ML solution for αi. Then,
∂L
∂αi
∝
∑
t,c
∂ε2t,c
∂αi
∝
∑
t,c
εt,cφi,t,c =
∑
(t,c)∈Φi
εt,c =
∑
(t,c)∈Φi
(log
Rt,c
R˜(−i),t,c
+ αi), (15)
where, as in the main text, Φi = {(t, c)|φi,t,c = 1} is the set of days and countries with NPI i active,
and R˜(−i),t,c is the predicted R ignoring the effect of NPI i:
R˜(−i),t,c = R0,c
∏
j∈I\{i}
exp(−αjφj,t,c) (16)
Setting ∂L∂αi = 0, we obtain:
−αi|Φi| =
∑
(t,c)∈Φi
log
Rt,c
R˜(−i),t,c
. (17)
By exponentiation and separation into two products, we obtain the theorem statement.
All that remains to show is that ∂
2L
∂α2i
< 0. Preserving signs, but not constants of proportionality, we
have:
∂L
∂αi
∝ −
∑
(t,c)∈Φi
εt,c ⇒ ∂
2L
∂α2i
∝ −
∑
(t,c)∈Φi
(1) < 0, (18)
as required.
Proof of Theorem 2. For this model, assume that ground truth values of gt,c have been given to us.
Expanding the definitions, we obtain
log gt,c = β(R
1/ν
0,c
∏
i∈I
(exp(−αiφi,t,c)1/ν)− 1) + εt,c (19)
where εt,c ∼ N (µ = 0, σ2 = σ2R); σR, ν, β and R0,c are fixed parameters, φi,t,c ∈ {0, 1} and gt,c
are given.
For each i ∈ I independently, we find the maximum likelihood solution αi given the other
{αj}j∈I,j 6=i in the point where ∂L/∂αi = 0. The log-likelihood takes the same form as in Eq. (14).
By differentiating, we obtain:
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∂L
∂αi
∝ −
∑
t,c
εt,c
∂εt,c
∂αi
(20)
where we have dropped constants of proportionality but kept the correct signs. Recalling Eq. 19, we
can write:
∂εt,c
∂αi
=
β
ν
R˜
1/ν
t,c φi,t,c ∝ R˜1/νt,c φi,t,c. (21)
R˜t,c is the predicted value of Rt,c given NPI effectiveness estimates {αi}i∈I (following Eq. 1 in the
main text).
Setting ∂L∂αi = 0 now yields:
−
∑
t,c
εt,cφi,t,cR˜
1/ν
t,c = 0⇒ exp(−αi/ν)
∑
(t,c)∈Φi
εt,cR˜
1/ν
(−i),t,c = 0 (22)
Then by expanding εt,c using Eq. 19 and expressing log gt,c in terms of Rt,c i.e., converting using
Assumption 8, we obtain:
∑
(t,c)∈Φi
R˜
1/ν
(−i),t,c
(
β(R¯
1/ν
t,c − 1)− β(R˜1/ν(−i),t,c exp(−αi)1/ν − 1)
)
= 0. (23)
R¯t,c is the value of Rt,c produced by converting ground truth values of gt,c using Assumption 8.
From this we obtain the theorem by simplification and rearranging.
All that remains is to show that ∂
2L
∂α2i
< 0. Keeping the signs but dropping constants of proportionality,
we have:
∂L
∂αi
∝ −
∑
(t,c)∈Φi
εt,cR˜
1/ν
t,c . (24)
Therefore:
∂2L
∂α2i
∝−
∑
(t,c)∈Φi
[
∂εt,c
∂αi
R˜
1/ν
t,c + εt,c
∂R˜
1/ν
t,c
∂αi
]
∝− β
ν
∑
(t,c)∈Φi
(
R˜
1/ν
t,c
)2
+
1
ν
∑
(t,c)∈Φi
εt,cR˜
1/ν
t,c︸ ︷︷ ︸
0 at ML solution
(25)
Combining Eqs. 20 and 21, we see that the second term is proportional to ∂L∂αi and therefore 0 at the
maximum likelihood solution. Given this, we have ∂
2L
∂α2i
< 0 at αi satisfying Eq. (23). Therefore, the
solution of Eq. (23) is the maximum likelihood solution.
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A.6 Experiment details
A.6.1 Data Preprocessing
We perform the same data preprocessing as in [8]:
• Our data for confirmed cases and deaths is given by the John Hopkins Centre for Systems
Science and Engineering[14, 15]. This data is noisy, so we smooth this data by averaging
the number of cases and deaths in a five day period around every day, assuming the data is
symmetric at the boundaries.
• We ignore new cases before a country has reached 100 cumulative confirmed cases, account-
ing for cases being imported from other countries and rapid changes in testing regime when
the case count is small.
• To avoid bias from imported deaths, we ignore new deaths before a country has reached 10
cumulative deaths.
A.6.2 Cross Validation
We perform four fold cross validation, holding all but the first fourteen days of cases and deaths
out for 6 regions at a time. We only considering predictions for regions which have greater than
100 deaths at the end of the time period we consider, since we are primarily interested in validating
holdout performance over long time periods. We do not hold out the first 14 days of cases and deaths
to allow the model to infer R0,c, N
(C)
0,c and N
(D)
0,c . The only way the model is able to explain held-out
data is through these parameters as well as the shared NPI effectiveness parameters, {αi}. We chose
a fixed set of four folds of cross validation randomly, which are:
Fold 1 = [DE, HU, FI, IE, RS, BE],
Fold 2 = [DK, GR, NO, FR, RO, NA],
Fold 3 = [ES, CZ, NL, CH, PT, AT],
Fold 4 = [IL, SE, IT, MX, GB, PL].
For these experiments, we run 4 chains with 2000 samples per chain.
A.6.3 Convergence Statistics
For all experiments, we ensure that Rˆ < 1.05 (i.e., there are no PyMC3 warnings) and that there are
no divergent transitions. For the baseline model, we have Rˆ ∈ [1.000, 1.004] for the vast majority of
parameters for the experiment with no held out data and default parameter settings.
A.6.4 Sensitivity Analyis
We summarise the sensitivity analysis tests we perform here. These are mostly as performed in [8].
Default values are highlighted in bold.
Epidemiological Parameter Uncertainty.
1. We shift the mean of the infection-to-confirmation distribution by [−2,−1,0, 1,+2] days.
2. We shift the mean of the infection-to-death distribution by [−2,−1,0, 1,+2] days.
3. We consider different serial intervals with mean values [4, 5, 6,6.67, 7, 8] days. These
distributions have the same standard deviation as the default distribution (4.88 days).
4. We change the mean value of the hyperprior of R0,c, R¯. We consider values
[log 1.25, log 3.25, log 5.5].
5. We change the prior over αi. For all models except the additive model, we try
N (0,0.22), N (0, 102), N+(0, 0.22). For the additive model, we use a Dirichlet(α)
prior, where the concentration parameter α is the same for all components. We consider
values [1, 5, 10].
Data Sensitivity.
1. We hold out regions [CZ, DE, MX, NL, PL, PT] (chosen randomly) one at a time.
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2. We change the cutoff below which confirmed COVID-19 cases are included in
[10, 30, 100, 300, 500].
3. We include Google mobility data as an additional NPI.
4. We modify the school closure feature in Sweden to be off rather than on. While [16] consider
this feature to be not active for Sweden, [8] consider it to be active.
5. We remove each NPI in turn from the data.
For sensitivity experiments, we run 8 chains with 1000 samples per chain.
A.7 Complete Model Descriptions
Note: We use the same notation as in the main text. Unless otherwise stated, all prior distributions
are independent.
A.7.1 Baseline Model
From [8].
• Data
1. NPI Activations: φi,t,c ∈ {0, 1}.
2. Smoothed Observed Cases: Ct,c.
3. Smoothed Observed Deaths: Dt,c.
• Prior Distributions
1. Country-specific R0,
R0,c = exp(R¯+ σRzc) (26)
R¯ ∼ Student T(µ = log(3.25), σ = 0.2, ν = 10) (27)
σR ∼ Half Student T(σ = 0.2, ν = 10) (28)
zc ∼ Normal(µ = 0, σ2 = 1) (29)
2. NPI Effectiveness:
αi ∼ Normal(µ = 0, σ2R = 0.2) (30)
(31)
3. Infection Initial Counts.
N
(C)
0,c = exp(ζ
(C)
c ) (32)
N
(D)
0,c = exp(ζ
(D)
c ) (33)
ζ(C)c ∼ Normal(µ = 0, σ2 = 502) (34)
ζ(D)c ∼ Normal(µ = 0, σ2 = 502) (35)
(36)
4. Observation Noise Dispersion Parameter
Ψ ∼ Half Normal(µ = 0, σ2 = 52) (37)
• Hyperparameters
1. Infection Noise Scale, σN = 0.2 (selected by cross-validation).
2. Serial Interval Parameters. The serial interval is assumed to have a Gamma distribu-
tion with α = 1.87 and β = 0.28. [3]
3. Delay Distributions. The time from infection to confirmation is assumed to be the
sum of the incubation period and the time taken from symptom onset to laboratory
confirmation. Therefore, the time taken from infection to confirmation, T (C) is:[4, 2,
3, 17]
T (C) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Negative Binomial(µ = 5.25, α = 1.57)
(38)
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The time from infection to death is assumed to be the sum of the incubation period and
the time taken from symptom onset to death. Therefore, the time taken from infection
to death, T (D) is:[4, 6]
T (D) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Gamma(µ = 18.8,
σ
µ
= 0.45), (39)
where α is known as the dispersion parameter. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of
the Negative Binomial distribution is µ+ µ
2
α .
For computational efficiency, we discretise this distribution using Monte Carlo sam-
pling. We therefore form discrete arrays, piC[i] and piD[i] where the value of piC[i]
corresponds to the probability of the delay being i days. We truncate piC to a maximum
delay of 31 days and piD to a maximum delay of 63 days.
• Infection Model
1. Rt,c = R0,c · exp
(
−∑9i=1 αi φi,t,c).
2. gt,c = exp
(
β(R
1
α
c,t − 1)
)
where α and β are the parameters of the serial interval
distribution. This is the exact conversion under exponential growth, following Eq. (2.9)
in Wallinga & Lipsitch.[18] (Note that we use daily growth rates.)
3.
N
(C)
t,c = N
(C)
0,c
t∏
τ=1
[
gτ,c · exp ε(C)τ,c
]
, (40)
N
(D)
t,c = N
(D)
0,c
t∏
τ=1
[
gτ,c · exp ε(D)τ,c )
]
,with noise (41)
ε(C)τ,c ∼ Normal(µ = 0, σ2 = σ2N ), (42)
ε(D)τ,c ∼ Normal(µ = 0, σ2 = σ2N ) (43)
N
(C)
t,c represents the number of daily new infections at time t in country c who will
eventually be tested positive (N (C)t,c similar but for infections who will pass away).
• Observation Model: We use discrete convolutions to produce the expected number of new
cases and deaths on a given day.
C¯t,c =
32∑
τ=1
N
(C)
t−τ,cpiC [τ ], (44)
D¯t,c =
64∑
τ=1
N
(D)
t−τ,cpiD[τ ]. (45)
Finally, the output distribution follows a Negative Binomial noise distribution as proposed
by Flaxman et al.[9]
Ct,c ∼ Negative Binomial(µ = C¯t,c, α = Ψ) (46)
Dt,c ∼ Negative Binomial(µ = D¯t,c, α = Ψ) (47)
α is the dispersion parameter of the distribution. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of the
Negative Binomial distribution is µ+ µ
2
α , so that smaller observations are relatively more
noisy.
A.7.2 Additive Effect Model
• Data
1. NPI Activations: φi,t,c ∈ {0, 1}.
2. Smoothed Observed Cases: Ct,c.
3. Smoothed Observed Deaths: Dt,c.
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• Prior Distributions
1. Country-specific R0,
R0,c = exp(R¯+ σRzc) (48)
R¯ ∼ Student T(µ = log(3.25), σ = 0.2, ν = 10) (49)
σR ∼ Half Student T(σ = 0.2, ν = 10) (50)
zc ∼ Normal(µ = 0, σ2 = 1) (51)
2. NPI Effectiveness:
αˆ, {αi} ∼ Dirichlet(α = 1) (52)
α is the concentration parameter of the Dirichlet distribution, and assumed to be the
same for all dimensions.
3. Infection Initial Counts.
N
(C)
0,c = exp(ζ
(C)
c ) (53)
N
(D)
0,c = exp(ζ
(D)
c ) (54)
ζ(C)c ∼ Normal(µ = 0, σ2 = 502) (55)
ζ(D)c ∼ Normal(µ = 0, σ2 = 502) (56)
(57)
4. Observation Noise Dispersion Parameter
Ψ ∼ Half Normal(µ = 0, σ2 = 52) (58)
• Hyperparameters
1. Infection Noise Scale, σN = 0.2 (selected by cross-validation).
2. Serial Interval Parameters. The serial interval is assumed to have a Gamma distribu-
tion with α = 1.87 and β = 0.28. [3]
3. Delay Distributions. The time from infection to confirmation is assumed to be the
sum of the incubation period and the time taken from symptom onset to laboratory
confirmation. Therefore, the time taken from infection to confirmation, T (C) is:[4, 2,
3, 17]
T (C) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Negative Binomial(µ = 5.25, α = 1.57)
(59)
The time from infection to death is assumed to be the sum of the incubation period and
the time taken from symptom onset to death. Therefore, the time taken from infection
to death, T (D) is:[4, 6]
T (D) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Gamma(µ = 18.8,
σ
µ
= 0.45), (60)
where α is known as the dispersion parameter. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of
the Negative Binomial distribution is µ+ µ
2
α .
For computational efficiency, we discretise this distribution using Monte Carlo sam-
pling. We therefore form discrete arrays, piC[i] and piD[i] where the value of piC[i]
corresponds to the probability of the delay being i days. We truncate piC to a maximum
delay of 31 days and piD to a maximum delay of 63 days.
• Infection Model
1. Rt,c = R0,c ·
[
αˆ+
∑
i∈I αi(1− φi,t,c)
]
.
2. gt,c = exp
(
β(R
1
α
c,t − 1)
)
where α and β are the parameters of the serial interval
distribution. This is the exact conversion under exponential growth, following eq. (2.9)
in Wallinga & Lipsitch.[18] (Note that we use daily growth rates.)
30
3.
N
(C)
t,c = N
(C)
0,c
t∏
τ=1
[
gτ,c · exp ε(C)τ,c
]
, (61)
N
(D)
t,c = N
(D)
0,c
t∏
τ=1
[
gτ,c · exp ε(D)τ,c )
]
,with noise (62)
ε(C)τ,c ∼ Normal(µ = 0, σ2 = σ2N ), (63)
ε(D)τ,c ∼ Normal(µ = 0, σ2 = σ2N ) (64)
N
(C)
t,c represents the number of daily new infections at time t in country c who will
eventually be tested positive (N (C)t,c similar but for infections who will pass away).
• Observation Model: We use discrete convolutions to produce the expected number of new
cases and deaths on a given day.
C¯t,c =
32∑
τ=1
N
(C)
t−τ,cpiC [τ ], (65)
D¯t,c =
64∑
τ=1
N
(D)
t−τ,cpiD[τ ]. (66)
Finally, the output distribution follows a Negative Binomial noise distribution as proposed
by Flaxman et al.[9]
Ct,c ∼ Negative Binomial(µ = C¯t,c, α = Ψ) (67)
Dt,c ∼ Negative Binomial(µ = D¯t,c, α = Ψ) (68)
α is the dispersion parameter of the distribution. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of the
Negative Binomial distribution is µ+ µ
2
α , so that smaller observations are relatively more
noisy.
A.7.3 Noisy-R Model
• Data
1. NPI Activations: φi,t,c ∈ {0, 1}.
2. Smoothed Observed Cases: Ct,c.
3. Smoothed Observed Deaths: Dt,c.
• Prior Distributions
1. Country-specific R0,
R0,c = exp(R¯+ σRzc) (69)
R¯ ∼ Student T(µ = log(3.25), σ = 0.2, ν = 10) (70)
σR ∼ Half Student T(σ = 0.2, ν = 10) (71)
zc ∼ Normal(µ = 0, σ2 = 1) (72)
2. NPI Effectiveness:
αi ∼ Normal(µ = 0, σ2R = 0.2) (73)
(74)
3. Infection Initial Counts.
N
(C)
0,c = exp(ζ
(C)
c ) (75)
N
(D)
0,c = exp(ζ
(D)
c ) (76)
ζ(C)c ∼ Normal(µ = 0, σ2 = 502) (77)
ζ(D)c ∼ Normal(µ = 0, σ2 = 502) (78)
(79)
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4. Observation Noise Dispersion Parameter
Ψ ∼ Half Normal(µ = 0, σ2 = 52) (80)
• Hyperparameters
1. Infection Noise Scale, σR = 0.7 (selected by cross-validation).
2. Serial Interval Parameters. The serial interval is assumed to have a Gamma distribu-
tion with α = 1.87 and β = 0.28. [3]
3. Delay Distributions. The time from infection to confirmation is assumed to be the
sum of the incubation period and the time taken from symptom onset to laboratory
confirmation. Therefore, the time taken from infection to confirmation, T (C) is:[4, 2,
3, 17]
T (C) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Negative Binomial(µ = 5.25, α = 1.57)
(81)
The time from infection to death is assumed to be the sum of the incubation period and
the time taken from symptom onset to death. Therefore, the time taken from infection
to death, T (D) is:[4, 6]
T (D) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Gamma(µ = 18.8,
σ
µ
= 0.45), (82)
where α is known as the dispersion parameter. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of
the Negative Binomial distribution is µ+ µ
2
α .
For computational efficiency, we discretise this distribution using Monte Carlo sam-
pling. We therefore form discrete arrays, piC[i] and piD[i] where the value of piC[i]
corresponds to the probability of the delay being i days. We truncate piC to a maximum
delay of 31 days and piD to a maximum delay of 63 days.
• Infection Model
1.
R
(C)
t,c = R0,c · exp
(
−
9∑
i=1
αi φi,t,c
)
· exp ε(C)τ,c (83)
R
(D)
t,c = R0,c · exp
(
−
9∑
i=1
αi φi,t,c
)
· exp ε(D)τ,c ,with noise (84)
ε(C)τ,c ∼ Normal(µ = 0, σ2 = σ2N ), (85)
ε(D)τ,c ∼ Normal(µ = 0, σ2 = σ2N ) (86)
2. gt,c = exp
(
β(R
1
α
c,t − 1)
)
− 1 where α and β are the parameters of the serial interval
distribution. This is the exact conversion under exponential growth, following eq. (2.9)
in Wallinga & Lipsitch.[18] (Note that we use daily growth rates.)
3.
N
(C)
t,c = N
(C)
0,c
t∏
τ=1
gτ,c, (87)
N
(D)
t,c = N
(D)
0,c
t∏
τ=1
gτ,c (88)
N
(C)
t,c represents the number of daily new infections at time t in country c who will
eventually be tested positive (N (C)t,c similar but for infections who will pass away).
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• Observation Model: We use discrete convolutions to produce the expected number of new
cases and deaths on a given day.
C¯t,c =
32∑
τ=1
N
(C)
t−τ,cpiC [τ ], (89)
D¯t,c =
64∑
τ=1
N
(D)
t−τ,cpiD[τ ]. (90)
Finally, the output distribution follows a Negative Binomial noise distribution as proposed
by Flaxman et al.[9]
Ct,c ∼ Negative Binomial(µ = C¯t,c, α = Ψ) (91)
Dt,c ∼ Negative Binomial(µ = D¯t,c, α = Ψ) (92)
α is the dispersion parameter of the distribution. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of the
Negative Binomial distribution is µ+ µ
2
α , so that smaller observations are relatively more
noisy.
A.7.4 Different Effects Model
• Data
1. NPI Activations: φi,t,c ∈ {0, 1}.
2. Smoothed Observed Cases: Ct,c.
3. Smoothed Observed Deaths: Dt,c.
• Prior Distributions
1. Country-specific R0,
R0,c = exp(R¯+ σRzc) (93)
R¯ ∼ Student T(µ = log(3.25), σ = 0.2, ν = 10) (94)
σR ∼ Half Student T(σ = 0.2, ν = 10) (95)
zc ∼ Normal(µ = 0, σ2 = 1) (96)
2. NPI Effectiveness:
αˆi ∼ Normal(µ = 0, σ2R = 0.22) (97)
αi,c ∼ Normal(µ = αˆi, σ2α = 0.12) (98)
(99)
3. Infection Initial Counts.
N
(C)
0,c = exp(ζ
(C)
c ) (100)
N
(D)
0,c = exp(ζ
(D)
c ) (101)
ζ(C)c ∼ Normal(µ = 0, σ2 = 502) (102)
ζ(D)c ∼ Normal(µ = 0, σ2 = 502) (103)
(104)
4. Observation Noise Dispersion Parameter
Ψ ∼ Half Normal(µ = 0, σ2 = 52) (105)
• Hyperparameters
1. Infection Noise Scale, σN = 0.2 (selected by cross-validation).
2. Country-Variation Scale, σα = 0.1 (selected by cross-validation).
3. Serial Interval Parameters. The serial interval is assumed to have a Gamma distribu-
tion with α = 1.87 and β = 0.28. [3]
4. Delay Distributions. The time from infection to confirmation is assumed to be the
sum of the incubation period and the time taken from symptom onset to laboratory
confirmation. Therefore, the time taken from infection to confirmation, T (C) is:[4, 2,
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3, 17]
T (C) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Negative Binomial(µ = 5.25, α = 1.57)
(106)
The time from infection to death is assumed to be the sum of the incubation period and
the time taken from symptom onset to death. Therefore, the time taken from infection
to death, T (D) is:[4, 6]
T (D) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Gamma(µ = 18.8,
σ
µ
= 0.45), (107)
where α is known as the dispersion parameter. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of
the Negative Binomial distribution is µ+ µ
2
α .
For computational efficiency, we discretise this distribution using Monte Carlo sam-
pling. We therefore form discrete arrays, piC[i] and piD[i] where the value of piC[i]
corresponds to the probability of the delay being i days. We truncate piC to a maximum
delay of 31 days and piD to a maximum delay of 63 days.
• Infection Model
1. Rt,c = R0,c · exp
(
−∑9i=1 αi,c φi,t,c).
2. gt,c = exp
(
β(R
1
α
c,t − 1)
)
− 1 where α and β are the parameters of the serial interval
distribution. This is the exact conversion under exponential growth, following eq. (2.9)
in Wallinga & Lipsitch.[18] (Note that we use daily growth rates.)
3.
N
(C)
t,c = N
(C)
0,c
t∏
τ=1
[
(gτ,c + 1) · exp ε(C)τ,c
]
, (108)
N
(D)
t,c = N
(D)
0,c
t∏
τ=1
[
(gτ,c + 1) · exp ε(D)τ,c )
]
,with noise (109)
ε(C)τ,c ∼ Normal(µ = 0, σ2 = σ2N ), (110)
ε(D)τ,c ∼ Normal(µ = 0, σ2 = σ2N ) (111)
N
(C)
t,c represents the number of daily new infections at time t in country c who will
eventually be tested positive (N (C)t,c similar but for infections who will pass away).
• Observation Model: We use discrete convolutions to produce the expected number of new
cases and deaths on a given day.
C¯t,c =
32∑
τ=1
N
(C)
t−τ,cpiC [τ ], (112)
D¯t,c =
64∑
τ=1
N
(D)
t−τ,cpiD[τ ]. (113)
Finally, the output distribution follows a Negative Binomial noise distribution as proposed
by Flaxman et al.[9]
Ct,c ∼ Negative Binomial(µ = C¯t,c, α = Ψ) (114)
Dt,c ∼ Negative Binomial(µ = D¯t,c, α = Ψ) (115)
α is the dispersion parameter of the distribution. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of the
Negative Binomial distribution is µ+ µ
2
α , so that smaller observations are relatively more
noisy.
A.7.5 Discrete Renewal Model
From [9].
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Note: this model uses only deaths as observations. In [9], they do not smooth the death observations.
Our implemention of this model uses different priors as compared to Flaxman et al. [9].
• Data
1. NPI Activations: φi,t,c ∈ {0, 1}.
2. Smoothed Observed Cases: Ct,c.
3. Smoothed Observed Deaths: Dt,c.
• Prior Distributions
1. Country-specific R0,
R0,c = exp(R¯+ σRzc) (116)
R¯ ∼ Student T(µ = log(3.25), σ = 0.2, ν = 10) (117)
σR ∼ Half Student T(σ = 0.2, ν = 10) (118)
zc ∼ Normal(µ = 0, σ2 = 1) (119)
2. NPI Effectiveness:
αi ∼ Normal(µ = 0, σ2R = 0.2) (120)
(121)
3. Infection Initial Counts.
N
(D)
0,c = exp(ζ
(D)
c ) (122)
ζ(D)c ∼ Normal(µ = 0, σ2 = 502) (123)
(124)
4. Observation Noise Dispersion Parameter
Ψ ∼ Half Normal(µ = 0, σ2 = 52) (125)
• Hyperparameters
1. Serial Interval Parameters. The serial interval is assumed to have a Gamma distribu-
tion with α = 1.87 and β = 0.28. [3] We discretise using Monte Carlo sampling to
form discrete array piSI[i] with a maximum delay of 27 days.
2. Delay Distributions. The time from infection to confirmation is assumed to be the
sum of the incubation period and the time taken from symptom onset to laboratory
confirmation. Therefore, the time taken from infection to confirmation, T (C) is:[4, 2,
3, 17]
T (C) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Negative Binomial(µ = 5.25, α = 1.57)
(126)
The time from infection to death is assumed to be the sum of the incubation period and
the time taken from symptom onset to death. Therefore, the time taken from infection
to death, T (D) is:[4, 6]
T (D) ∼ Gamma(µ = 5.1, σ
µ
= 0.86) + Gamma(µ = 18.8,
σ
µ
= 0.45), (127)
where α is known as the dispersion parameter. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of
the Negative Binomial distribution is µ+ µ
2
α .
For computational efficiency, we discretise this distribution using Monte Carlo sam-
pling. We therefore form discrete arrays, piC[i] and piD[i] where the value of piC[i]
corresponds to the probability of the delay being i days. We truncate piC to a maximum
delay of 31 days and piD to a maximum delay of 63 days.
• Infection Model
1. Rt,c = R0,c · exp
(
−∑9i=1 αi φi,t,c).
2. gt,c = exp
(
β(R
1
α
c,t − 1)
)
− 1 where α and β are the parameters of the serial interval
distribution. This is the exact conversion under exponential growth, following eq. (2.9)
in Wallinga & Lipsitch.[18] (Note that we use daily growth rates.)
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3.
N
(C)
t,c = N
(C)
0,c
t∏
τ=1
[
(gτ,c + 1) · exp ε(C)τ,c
]
, (128)
N
(D)
t,c = N
(D)
0,c
t∏
τ=1
[
(gτ,c + 1) · exp ε(D)τ,c )
]
,with noise (129)
ε(C)τ,c ∼ Normal(µ = 0, σ2 = σ2N ), (130)
ε(D)τ,c ∼ Normal(µ = 0, σ2 = σ2N ) (131)
N
(C)
t,c represents the number of daily new infections at time t in country c who will
eventually be tested positive (N (C)t,c similar but for infections who will pass away).
• Observation Model: We use discrete convolutions to produce the expected number of new
cases and deaths on a given day.
C¯t,c =
32∑
τ=1
N
(C)
t−τ,cpiC [τ ], (132)
D¯t,c =
64∑
τ=1
N
(D)
t−τ,cpiD[τ ]. (133)
Finally, the output distribution follows a Negative Binomial noise distribution as proposed
by Flaxman et al.[9]
Ct,c ∼ Negative Binomial(µ = C¯t,c, α = Ψ) (134)
Dt,c ∼ Negative Binomial(µ = D¯t,c, α = Ψ) (135)
α is the dispersion parameter of the distribution. Caution: larger values of α correspond
to a smaller variance, and less dispersion. With our parameterisation, the variance of the
Negative Binomial distribution is µ+ µ
2
α , so that smaller observations are relatively more
noisy.
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